<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Immunogenicity | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="When a patient receives a blood transfusion, their immune system may encounter red cell antigens different from their own. Immunogenicity refers to the likelihood that a particular foreign blood...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Immunogenicity | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="When a patient receives a blood transfusion, their immune system may encounter red cell antigens different from their own. Immunogenicity refers to the likelihood that a particular foreign blood...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Immunogenicity | Blood Bank">
<meta name="twitter:description" content="When a patient receives a blood transfusion, their immune system may encounter red cell antigens different from their own. Immunogenicity refers to the likelihood that a particular foreign blood...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="active" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="immunogenicity" class="section level1 unnumbered">
<h1>Immunogenicity<a class="anchor" aria-label="anchor" href="#immunogenicity"><i class="fas fa-link"></i></a>
</h1>
<p>When a patient receives a blood transfusion, their immune system may encounter red cell antigens different from their own. <strong>Immunogenicity</strong> refers to the likelihood that a particular foreign blood group antigen will stimulate the recipient to produce an antibody against it (a process called alloimmunization). This concept is crucial because some antigens, like the D antigen in the Rh system, are highly immunogenic and frequently cause antibody formation, while others rarely do. Understanding immunogenicity helps predict which antigen differences are most likely to lead to clinically significant antibodies, impacting transfusion safety and the potential for future compatibility issues</p>
<div id="immunogenicity-the-power-to-provoke-1" class="section level2 unnumbered">
<h2>Immunogenicity: The Power to Provoke<a class="anchor" aria-label="anchor" href="#immunogenicity-the-power-to-provoke-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Immunogenicity refers to the <strong>relative ability</strong> of a specific blood group antigen to stimulate an antibody response (alloantibody formation) when introduced into an individual who lacks that antigen</li>
<li>
<strong>Alloimmunization:</strong> The process of forming antibodies against foreign antigens from the same species (e.g., a human forming an antibody to a human blood group antigen they lack)</li>
</ul>
</div>
<div id="what-makes-an-antigen-more-immunogenic" class="section level2 unnumbered">
<h2>What Makes an Antigen More Immunogenic?<a class="anchor" aria-label="anchor" href="#what-makes-an-antigen-more-immunogenic"><i class="fas fa-link"></i></a>
</h2>
<p>Several factors contribute, but from a practical blood bank perspective, the key drivers are:</p>
<ul>
<li>
<strong>Foreignness:</strong> The antigen must be recognized as non-self. This is inherent in blood group differences between donor and recipient</li>
<li>
<strong>Chemical Nature &amp; Complexity:</strong> Generally, <strong>proteins</strong> are more immunogenic than carbohydrates because they can be processed and presented by antigen-presenting cells to T-helper cells, leading to a robust IgG antibody response. Large, complex molecules are often better targets</li>
<li>
<strong>Structure &amp; Accessibility:</strong> How the antigen is presented on the cell surface matters</li>
<li>
<strong>Dose &amp; Exposure:</strong> The amount of antigen introduced (e.g., the number of RBCs transfused) and the frequency of exposure can influence the likelihood and strength of the response</li>
</ul>
</div>
<div id="the-immunogenicity-hit-parade-who-causes-the-most-trouble" class="section level2 unnumbered">
<h2>The Immunogenicity Hit Parade: Who Causes the Most Trouble?<a class="anchor" aria-label="anchor" href="#the-immunogenicity-hit-parade-who-causes-the-most-trouble"><i class="fas fa-link"></i></a>
</h2>
<p>Based on decades of transfusion experience, we know some antigens are much more likely to cause alloimmunization than others. Here’s a general ranking of the most clinically significant immunogens encountered in RBC transfusion:</p>
<ol style="list-style-type: decimal">
<li>
<strong>D (Rh System)</strong> <strong>By far the most immunogenic</strong> blood group antigen outside of the ABO system. Studies show that ~80% of D-negative individuals transfused with a single unit of D-positive RBCs will develop anti-D if no preventative measures (like RhIG) are taken. This is why preventing anti-D formation is a cornerstone of transfusion practice</li>
<li>
<strong>K (Kell System)</strong> Considered the <strong>most immunogenic after D</strong>. While the K antigen has a lower prevalence (~9% in Caucasians), exposure readily stimulates anti-K production in K-negative individuals. Anti-K is a common cause of delayed HTR and HDFN</li>
<li>
<strong>Other Rh Antigens (c, E, C, e)</strong> These protein antigens are also significantly immunogenic, generally ranked in approximately this order of likelihood to stimulate antibody production: <strong>c &gt; E &gt; C &gt; e</strong>. Matching for these antigens is often considered for chronically transfused patients</li>
<li>
<strong>Kidd Antigens (Jk<sup>a</sup>, Jk<sup>b</sup>)</strong> Known to be immunogenic. Anti-Jk<sup>a</sup> and anti-Jk<sup>b</sup> are notorious for causing <strong>delayed hemolytic transfusion reactions</strong>, partly because the antibody levels can decline over time (making them hard to detect pre-transfusion) but then reappear strongly after re-exposure (anamnestic response)</li>
<li>
<strong>Duffy Antigens (Fy<sup>a</sup>, Fy<sup>b</sup>)</strong> Moderately immunogenic. Anti-Fy<sup>a</sup> is more common than anti-Fy<sup>b</sup> and can cause HTR and HDFN</li>
<li>
<strong>MNS System Antigens (S, s)</strong> S and s are significantly more immunogenic than M and N. Anti-S and anti-s can cause HTR and HDFN. (While M and N <em>can</em> stimulate antibodies, anti-M is often naturally occurring IgM and less often clinically significant post-transfusion compared to anti-S/s)</li>
</ol>
<p><strong>What about ABO?</strong>
ABO antigens (A and B) are highly immunogenic carbohydrates. However, the “antibodies” (isoagglutinins anti-A and anti-B) are typically <strong>naturally occurring</strong>. They develop early in life presumably due to exposure to similar carbohydrate structures in the environment (bacteria, food). Therefore, the primary concern with ABO isn’t <em>post-transfusion alloimmunization</em> in the same way as with D or K, but rather the immediate, severe <em>hemolytic reaction</em> if ABO-incompatible blood is transfused due to these pre-existing, potent antibodies</p>
</div>
<div id="factors-influencing-the-recipients-response" class="section level2 unnumbered">
<h2>Factors Influencing the <em>Recipient’s</em> Response<a class="anchor" aria-label="anchor" href="#factors-influencing-the-recipients-response"><i class="fas fa-link"></i></a>
</h2>
<p>It’s not just the antigen – the recipient’s immune system plays a role too:</p>
<ul>
<li>
<strong>Immune Status:</strong> Immunocompromised patients may be less likely to form antibodies</li>
<li>
<strong>Genetic Predisposition:</strong> Some individuals seem to be “responders” more prone to making antibodies than others</li>
<li>
<strong>Previous Sensitization:</strong> Once sensitized, subsequent exposure leads to a faster, stronger <strong>anamnestic response</strong>
</li>
</ul>
</div>
<div id="clinical-significance-why-we-care" class="section level2 unnumbered">
<h2>
<strong>Clinical Significance: Why We Care</strong><a class="anchor" aria-label="anchor" href="#clinical-significance-why-we-care"><i class="fas fa-link"></i></a>
</h2>
<p>Alloimmunization due to immunogenic blood group antigens is clinically important because the resulting antibodies (usually IgG) can:</p>
<ul>
<li>Cause <strong>Hemolytic Transfusion Reactions (HTR)</strong>: Destruction of transfused red blood cells, leading to anemia, jaundice, fever, and potentially life-threatening complications like shock and renal failure. Can be acute or delayed</li>
<li>Cause <strong>Hemolytic Disease of the Fetus and Newborn (HDFN)</strong>: Maternal IgG antibodies crossing the placenta and destroying fetal red blood cells expressing the corresponding antigen inherited from the father</li>
<li>
<strong>Make finding compatible blood difficult:</strong> Patients with multiple antibodies or antibodies to high-prevalence antigens pose significant challenges</li>
</ul>
</div>
<div id="managing-immunogenicity-in-transfusion-practice" class="section level2 unnumbered">
<h2>
<strong>Managing Immunogenicity in Transfusion Practice</strong><a class="anchor" aria-label="anchor" href="#managing-immunogenicity-in-transfusion-practice"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>ABO/RhD Typing:</strong> Standard practice to prevent immediate hemolysis (ABO) and primary anti-D immunization</li>
<li>
<strong>Antibody Screening:</strong> Detecting pre-existing antibodies to ensure antigen-negative blood is provided</li>
<li>
<strong>RhIG (RhoGAM):</strong> Given to D-negative mothers during pregnancy and after delivery of a D-positive baby (and in other sensitizing events) to prevent the formation of anti-D</li>
<li>
<strong>Prophylactic Antigen Matching:</strong> For chronically transfused patients (e.g., sickle cell disease), often matched for Rh (C, E) and K antigens, and sometimes Kidd/Duffy, to prevent alloimmunization to these highly immunogenic antigens</li>
</ul>
<p>In summary, immunogenicity dictates which blood group differences are most likely to cause problems following transfusion or pregnancy. The D antigen stands out as the most potent, followed by K and other Rh antigens, highlighting the importance of careful donor selection and preventative strategies</p>
</div>
<div id="key-terms-46" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-46"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Immunogenicity:</strong> The ability of an antigen to provoke an immune response (antibody formation)</li>
<li>
<strong>Alloimmunization:</strong> The process of forming antibodies against antigens from another individual of the same species</li>
<li>
<strong>Alloantibody:</strong> An antibody produced against a foreign antigen from the same species</li>
<li>
<strong>Antigen:</strong> A molecule (usually protein or carbohydrate) recognized by the immune system</li>
<li>
<strong>Seroconversion:</strong> The development of detectable antibodies in the blood serum as a result of infection or immunization</li>
<li>
<strong>Anamnestic Response:</strong> A rapid and heightened immune response following re-exposure to an antigen to which the individual has been previously sensitized</li>
<li>
<strong>Hemolytic Transfusion Reaction (HTR):</strong> Destruction of transfused red blood cells by recipient antibodies</li>
<li>
<strong>Hemolytic Disease of the Fetus and Newborn (HDFN):</strong> Destruction of fetal/newborn red blood cells by maternal antibodies that crossed the placenta</li>
<li>
<strong>RhIG (Rh Immune Globulin):</strong> A preparation of concentrated anti-D antibodies given to prevent D-negative individuals from forming their own anti-D after exposure to D-positive red cells</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  sections = [];
  topics = [];
  function hide_label() {
    // sections
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          elem.classList
          .contains('book-part')
          ? sections.push(elem)
          : '';
      });

    // topics
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? topics.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    // sections
    count_sections = 0;
    prev_sections_elem = '';
    sections
      .forEach((elem) => {
      if(count_sections === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_sections = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_sections_elem.classList.add('hide_label');
        } else {
          prev_sections_elem.classList.remove('hide_label');
        }
      }
      prev_sections_elem = elem;
    });
    // topics
    count_topics = 0;
    prev_topic_elem = '';
    topics
      .forEach((elem) => {
      if(count_topics === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_topics = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_topic_elem.classList.add('hide_label');
        } else {
          prev_topic_elem.classList.remove('hide_label');
        }
      }
      prev_topic_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></div>
<div class="next"><a href="antigen-prevalence.html">Antigen Prevalence</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#immunogenicity">Immunogenicity</a></li>
<li><a class="nav-link" href="#immunogenicity-the-power-to-provoke-1">Immunogenicity: The Power to Provoke</a></li>
<li><a class="nav-link" href="#what-makes-an-antigen-more-immunogenic">What Makes an Antigen More Immunogenic?</a></li>
<li><a class="nav-link" href="#the-immunogenicity-hit-parade-who-causes-the-most-trouble">The Immunogenicity Hit Parade: Who Causes the Most Trouble?</a></li>
<li><a class="nav-link" href="#factors-influencing-the-recipients-response">Factors Influencing the Recipient’s Response</a></li>
<li><a class="nav-link" href="#clinical-significance-why-we-care">Clinical Significance: Why We Care</a></li>
<li><a class="nav-link" href="#managing-immunogenicity-in-transfusion-practice">Managing Immunogenicity in Transfusion Practice</a></li>
<li><a class="nav-link" href="#key-terms-46">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/02-C-01.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/02-C-01.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-08 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
